SOPHiA GENETICS to Report Second Quarter 2021 Financial Results on September 9, 2021
BOSTON and LAUSANNE, Switzerland, Aug. 26, 2021 (GLOBE NEWSWIRE) — SOPHiA GENETICS SA (Nasdaq: SOPH)…
BOSTON and LAUSANNE, Switzerland, Aug. 26, 2021 (GLOBE NEWSWIRE) — SOPHiA GENETICS SA (Nasdaq: SOPH)…
On average, pediatric congenital athymia patients spent 150.6 days each year in the hospital with…
FREMONT, CA, Aug. 26, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ:…
SANTA CLARA, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a…
SANTA MONICA, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) — GoodRx Holdings Inc. (Nasdaq: GDRX), America’s…
NXP800 is a novel, oral, small molecule heat shock factor 1 (HSF1) pathway inhibitor discovered…
Developing a new era of precision medicines using a unique and proprietary drug discovery platform DURHAM,…
CARLSBAD, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) — Pardes Biosciences, Inc., a clinical-stage biopharmaceutical company…
CRANBURY, N.J., Aug. 26, 2021 (GLOBE NEWSWIRE) — Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”),…
CRISPR-based therapies as a curative approach to HIV infection included in the program for first…
TORONTO, Aug. 26, 2021 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…
Zogenix plans to submit a new drug application (J-NDA) for FINTEPLA in Japan for the…
– Established three clinical collaborations with Merck to conduct global combination trials with pembrolizumab for three…
Name change underscores the Company’s transition to developing innovative targeted therapies in immunology, immuno-oncology, and…
RESEARCH TRIANGLE PARK, N.C., Aug. 26, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today…
BLACKSBURG, Va., Aug. 26, 2021 (GLOBE NEWSWIRE) — Landos Biopharma, Inc. (NASDAQ: LABP), a late-clinical-stage…
Wanchunbulin, BeyondSpring’s 58%-owned subsidiary in China, to partner with Hengrui, the leader in oncology product…
NEW YORK, Aug. 26, 2021 (GLOBE NEWSWIRE) — Today, Verizon issued its Green Bond Impact…
ORBCOMM to support Cradlepoint as a leading partner in bringing powerful 5G technology to global…
Acumen Research and Consulting, a global provider of market research studies, in a recently published…